Stella Wilson

Info

9 posts
https://www.rootsanalysis.com/
Working at Johnson Matthey Sdn Bhd
Studying at What After MBA
Living in United States of America
Located in Sacramento, California, United States of America

More info

Designation :	Manager
Job Skill :	Client Management
Work Experience :	2 Years

Albums

0

0

0

Groups

0

created a new article

Manager at Johnson Matthey Sdn Bhd

3 years ago

Covid-19 Updates | Cell Therapy Manufacturing Market is estimated to reach close to USD 11 Billion by 2030 | #Cell Therapy Manufacturing

Covid-19 Updates | Cell Therapy Manufacturing Market is estimated to reach close to USD 11 Billion by 2030

Covid-19 Updates | Cell Therapy Manufacturing Market is estimated to reach close to USD 11 Billion by 2030

Manufacturing cell therapies is technically and financially demanding; as a result, despite therapy developers gradually strengthening their in-house expertise, they are also becoming increasingly reliant on contract service providers

Like

Comment

Share

created a new article

Manager at Johnson Matthey Sdn Bhd

3 years ago

Covid-19 Updates | Biopharmaceutical Contract Manufacturing Market is estimated to be worth USD 13.9 billion in 2030 | #Biopharmaceutical Contract Manufacturing

Covid-19 Updates | Biopharmaceutical Contract Manufacturing Market is estimated to be worth USD 13.9 billion in 2030

Covid-19 Updates | Biopharmaceutical Contract Manufacturing Market is estimated to be worth USD 13.9 billion in 2030

Outsourcing has become a popular trend among biopharmaceutical developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages

Like

Comment

Share

created a new article

Manager at Johnson Matthey Sdn Bhd

3 years ago

Covid-19 Updates | Antibody Contract Manufacturing Market is estimated to be worth USD 17 billion in 2030 | #Antibody Contract Manufacturing #Antibody Contract Manufacturing Market #Antibody Contract Manufacturing Market Research Report #Antibody Contract Manufacturing Market size #Antibody Contract Manufacturing Market growth #Antibody Contract Manufacturing Market revenue #Antibody Contract Manufacturing Market Analysis #Antibody Contract Manufacturing Industry Forecast

Covid-19 Updates | Antibody Contract Manufacturing Market is estimated to be worth USD 17 billion in 2030

Covid-19 Updates | Antibody Contract Manufacturing Market is estimated to be worth USD 17 billion in 2030

The benefits of engaging a CMO or CDMO for antibody development and production extend beyond fulfilling the needs of small companies; access to new technologies and operational flexibility are attractive attributes to larger players as well

Like

Comment

Share

created a new article

Manager at Johnson Matthey Sdn Bhd

3 years ago

Target Protein Degradation Market is projected to be over USD 3.6 billion by 2030 | Roots Analysis | #Target Protein Degradation #Target Protein Degradation Market #Target Protein Degradation Market Research Report #Target Protein Degradation Market size #Target Protein Degradation Market growth #Target Protein Degradation Market revenue #Target Protein Degradation Market Analysis #Target Protein Degradation Industry Forecast

Target Protein Degradation Market is projected to be over USD 3.6 billion by 2030 | Roots Analysis

Target Protein Degradation Market is projected to be over USD 3.6 billion by 2030 | Roots Analysis

More than 85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications; in addition, there are over 25 technology platforms available for use in therapy development efforts

Like

Comment

Share

created a new article

Manager at Johnson Matthey Sdn Bhd

3 years ago

Subcutaneous Biologic Drugs and Affiliated Technologies Market is projected to be worth over USD 180 billion by 2030 | #Subcutaneous Biologic Drugs and Affiliated Technologies #Subcutaneous Biologic Drugs and Affiliated Technologies Market #Subcutaneous Biologic Drugs and Affiliated Technologies Market Research Report #Subcutaneous Biologic Drugs and Affiliated Technologies Market size #Subcutaneous Biologic Drugs and Affiliated Technologies Market growth #Subcutaneous Biologic Drugs and Affiliated Technologies Market revenue #Subcutaneous Biologic Drugs and Affiliated Technologies Market Analysis #Subcutaneous Biologic Drugs and Affiliated Technologies Industry Forecast

Subcutaneous Biologic Drugs and Affiliated Technologies Market is projected to be worth over USD 180 billion by 2030

Subcutaneous Biologic Drugs and Affiliated Technologies Market is projected to be worth over USD 180 billion by 2030

More than 100 subcutaneous biologics have been approved and over 350 such drug candidates are being evaluated in the clinical stages of development, for the treatment of a wide variety of disease indications, claims Roots Analysis

Like

Comment

Share

Load more posts